Ampio Pharmaceuticals (AMPE) Stock Chart & Stock Price History $0.0029 0.00 (0.00%) As of 08/7/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Ampio Pharmaceuticals Stock Price Performance The Ampio Pharmaceuticals (AMPE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 1,350.00%, with a year-to-date return of 11.54%. In the past month, the stock has increased 7.41%, reflecting recent market activity. As of the latest close, Ampio Pharmaceuticals traded at $0.00 with a market cap of $3 thousand and volume of 8 shares. Five years ago, the stock traded at a split-adjusted price of $20.40, representing a 99.99% decrease over that period. At the time, it had a market cap of $187.14 million and a volume of 86,690 shares. Receive AMPE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ampio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance+7.41%3 Month Performance+7.41%Year-To-Date Performance+11.54%1 Year Performance+1,350.00%5 Year Performance-99.99% AMPE Stock Chart for Friday, August, 8, 2025 AMPE Chart by TradingView Ampio Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025$0.00$0.00$0.00$0.008 shs$3,000.0008/06/2025$0.00$0.00$0.00$0.008 shs$3,000.0008/05/2025$0.00$0.00$0.00$0.0010 shs$3,000.0008/04/2025$0.00$0.00$0.00$0.001 shs$3,000.0008/01/2025$0.00$0.00$0.00$0.0068 shs$3,000.0007/31/2025$0.00$0.00$0.00$0.00349 shs$3,000.0007/30/2025$0.00$0.00+3.57%$0.00$0.00349 shs$3,000.0007/29/2025$0.00$0.00$0.00$0.0036 shs$3,000.0007/28/2025$0.00$0.00$0.00$0.00268 shs$3,000.0007/25/2025$0.00$0.00+3.70%$0.00$0.00268 shs$3,000.00 Get the Latest News and Ratings for AMPE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ampio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025$0.00$0.00$0.00$0.0069 shs$3,000.0007/23/2025$0.00$0.00$0.00$0.00578 shs$3,000.0007/22/2025$0.00$0.00$0.00$0.00578 shs$3,000.0007/21/2025$0.01$0.00-73.00%$0.00$0.00243 shs$3,000.0007/18/2025$0.01$0.01$0.01$0.016 shs$11,000.0007/17/2025$0.01$0.01$0.01$0.0113 shs$11,000.0007/16/2025$0.01$0.01$0.01$0.017,588 shs$11,000.0007/15/2025N/A$0.01$0.01$0.017,588 shs$11,000.0007/11/2025$0.00$0.00$0.00$0.00106 shs$0.0007/10/2025$0.00$0.00-96.30%$0.00$0.00106 shs$0.0007/09/2025$0.00$0.00$0.00$0.00131 shs$3,000.0007/08/2025$0.00$0.00-32.50%$0.00$0.00131 shs$3,000.0007/07/2025N/A$0.00$0.00$0.00272 shs$5,000.00 Related Companies Evelo Biosciences Stock Chart Comera Life Sciences Stock Chart Genocea Biosciences Stock Chart Genocea Biosciences Stock Chart Aridis Pharmaceuticals Stock Chart Statera Biopharma Stock Chart Calithera Biosciences Stock Chart eFFECTOR Therapeutics Stock Chart Histogen Stock Chart OncoSec Medical Stock Chart Receive AMPE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ampio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:AMPE) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ampio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ampio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
